We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
This protocol is written to conduct an in vitro drug release study in human plasma, comparing drug release of a bilayer-loaded docetaxel (DTX) nanoliposome to the commercial DTX formulation, Taxotere®, and solvent solubilized DTX.
